The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDODS.L Regulatory News (DODS)

  • There is currently no data for DODS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

9 Feb 2007 16:23

Huveaux PLC09 February 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): Huveaux PLC 2. Reason for the notification (please place an X inside the appropriate bracket/s): An acquisition or disposal of voting rights: ( X ) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation (iii): AXA S.A, 25 Avenue Matignon, 75008 Paris and its group of companies. 4. Full name of shareholder(s) (if different from 3.) (iv): ................. 5. Date of the transaction (and date on which the threshold is crossed orreached if different) (v): 07/02/2007 6. Date on which issuer notified: 08/02/2007 7. Threshold(s) that is/are crossed or reached: 15% 8. Notified details: ................. A: Voting rights attached to shares Class/type of shares if Situation previous to the Triggering transaction (vi)possible using the ISINCODE Number of shares Number of voting Rights (viii)Ord 3112957 31,667,790 31,667,790 Resulting situation after the triggering transaction (vii) Class/type of shares Number of Number of voting rights % of votingif possible using shares (ix) rightsthe ISIN CODE Direct Direct (x) Indirect (xi) Direct Indirect Ord 3112957 8,913,045 8,913,045 22,954,745 5.86% 15.10% B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of Expiration Exercise/ Number of voting rights that may % offinancial Date Conversion be acquired if the instrument is votinginstrument (xiii) Period/ Date exercised/ converted. rights (xiv) Total (A+B)Number of voting rights % of voting rights 31,867,790 20.96% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): AXA Framlington 1,247,964 0.82% (Non - Beneficial)(Xerox Final Salary Pension Scheme) AXA Framlington 756,000 0.50% (Non - Beneficial)(Islington Group Pension Scheme) AXA Framlington 1,650,000 1.09% (Non - Beneficial)(SEI UK Equity) AXA Framlington 1,750,000 1.15% (Non - Beneficial)(Skandia UK global Best Ideas - GL) AXA Framlington 10,686,740 7.03% (Non - Beneficial)(Monthly Income) AXA Framlington 4,800,000 3.16% (Non - Beneficial)(UK Smaller Companies) AXA Framlington 1,085,479 0.71% (Non - Beneficial)(BAE Systems Pensions Fund CIF Trustees) AXA Framlington 475,647 0.31% (Non - Beneficial)(BAE Systems 2000 Pensions Fund) Framlington onshore private clients 502,915 0.33% (Non - Beneficial) Please note that this notification includes a disclosure on behalf of thefollowing Investment Trust Companies which has/have a notifiable interest. Theinterest of each Trust is listed below - AXA Framlington Throgmorton Trust 6,500,0004.28 % (Beneficial) Framlington Innovation Growth 2,413,045 1.59 % (Beneficial) Proxy Voting: 10. Name of the proxy holder: ................. 11. Number of voting rights proxy holder will cease to hold: ................. 12. Date on which proxy holder will cease to hold voting rights: ................. 13. Additional information: ................. 14. Contact name: Terry Marsh 15. Contact telephone number: 020 7003 2637 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Apr 20214:05 pmRNSHolding(s) in Company
16th Apr 202111:30 amRNSResult of General Meeting
1st Apr 20217:00 amRNSPosting of Circular and Notice of GM
30th Mar 20217:01 amRNSChange of Name and Share Capital Reorganisation
30th Mar 20217:00 amRNSTrading Update
30th Nov 20207:00 amRNSHalf-year Report
26th Nov 202011:35 amRNSBoard Changes
12th Oct 20204:23 pmRNSHolding(s) in Company
29th Sep 202012:21 pmRNSResult of AGM
4th Sep 202012:31 pmRNSAnnual Financial Report
3rd Sep 20207:02 amRNSFinal Results
3rd Sep 20207:00 amRNSAppointment of Nominated Adviser and Sole Broker
5th Aug 20202:02 pmRNSHolding(s) in Company
29th Jul 20207:00 amRNSIssue of Shares and Director / PDMR Dealing
1st Jul 202010:52 amRNSDirectorate Change
18th Jun 20207:00 amRNSDr David Hammond
1st Jun 20202:06 pmRNSBoard Appointments
1st Jun 20207:00 amRNSUpdated Debt Facilities
23rd Apr 20207:06 amRNSAppointment of CFO and COVID-19 Update
18th Mar 20205:46 pmRNSAIM Rule 17 Notification
24th Feb 20203:47 pmRNSDirectorate Change
22nd Jan 20202:52 pmRNSDirectorate Change
22nd Jan 20207:00 amRNSTrading Update
29th Oct 20197:00 amRNSHalf-year Report
26th Sep 20197:00 amRNSChange of Adviser
25th Sep 20198:59 amRNSAIM Rule 17 Schedule Two (g) Update
2nd Sep 20197:00 amRNSDirectorate Change
29th Aug 20194:07 pmRNSResult of AGM
23rd Jul 20197:00 amRNSHolding(s) in Company
23rd Jul 20197:00 amRNSHolding(s) in Company
18th Jul 20191:42 pmRNSCompletion of Acquisition
18th Jul 20198:48 amRNSDirector/PDMR Shareholding
18th Jul 20198:46 amRNSAnnual Financial Report
16th Jul 201910:39 amRNSResult of General Meeting and Open Offer
28th Jun 20198:47 amRNSGeneral Meeting & Open Offer Timetable
28th Jun 20197:00 amRNSAcquisition, Fundraising and Notice of GM
28th Jun 20197:00 amRNSFinal Results
11th Jun 20197:00 amRNSAcquisition of Meritgroup
10th Jun 20197:00 amRNSResponse re. Press Speculation
21st May 20197:00 amRNSAppointment of Chief Revenue Officer
29th Apr 20197:00 amRNSAppointment of Chief Information Officer
21st Jan 20197:00 amRNSTrading Statement
5th Dec 20181:50 pmRNSHolding(s) in Company
5th Dec 20181:50 pmRNSHolding(s) in Company
14th Nov 20187:00 amRNSHalf-year Report
21st Sep 201811:17 amRNSLong Term Incentive Plan
14th Aug 201812:39 pmRNSDirectorate Change
7th Aug 20184:14 pmRNSDirector/PDMR Shareholding
1st Aug 20189:52 amRNSDirectorate Change
1st Aug 20189:24 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.